A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

NCT07265921 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Cancer

Interventions

DRUG: SIM0609 for injection
DRUG: dose expansion of SIM0609 in CRC
DRUG: dose expansion of SIM0609 in GC/GEJC cohort
DRUG: dose expansion of SIM0609 in PDAC cohort
DRUG: dose expansion of SIM0609 in positive other solid tumors

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Collaborators

[object Object]